| 000 | 00959 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250516040959.0 | ||
| 264 | 0 | _c20120507 | |
| 008 | 201205s 0 0 eng d | ||
| 022 | _a1744-8042 | ||
| 024 | 7 |
_a10.2217/pgs.11.29 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWatanabe, Richard M | |
| 245 | 0 | 0 |
_aDrugs, diabetes and pharmacogenomics: the road to personalized therapy. _h[electronic resource] |
| 260 |
_bPharmacogenomics _cMay 2011 |
||
| 300 |
_a699-701 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aDiabetes Mellitus _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aPharmaceutical Preparations _xadministration & dosage |
| 650 | 0 | 4 |
_aPharmacogenetics _xmethods |
| 650 | 0 | 4 |
_aPrecision Medicine _xmethods |
| 773 | 0 |
_tPharmacogenomics _gvol. 12 _gno. 5 _gp. 699-701 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2217/pgs.11.29 _zAvailable from publisher's website |
| 999 |
_c20879840 _d20879840 |
||